Introduction
============

Daily rhythms in behavior and physiology are regulated by the circadian system, a hierarchical group of biologic clocks widely distributed in mammalian tissues. The central clock of the circadian system, located in the suprachiasmatic nucleus (SCN) of the hypothalamus, is synchronized by the day/night cycle and coordinates the phases of many peripheral clocks \[[@r1]\]. Photic entrainment of the SCN clock involves rods, cones, and melanopsin-containing light-sensitive retinal ganglion cells, or intrinsically photosensitive retinal ganglion cells (ipRGCs) \[[@r2]-[@r6]\]. The mammalian retina also contains a light synchronized circadian clock that controls many aspects of retinal physiology, including photoreceptor disc shedding \[[@r7]\], melatonin release \[[@r8]-[@r10]\], and dopamine synthesis \[[@r11],[@r12]\].

The cell autonomous oscillations in both central and peripheral clocks involve autoregulatory positive and negative transcriptional and translational feedback loops that are composed of a set of clock genes including brain and muscle aryl-hydrocarbon receptor nuclear translocator-like protein-1 (Bmal1), circadian locomotor output cycles kaput (*Clock*), period (*Per1*, *Per2* and *Per3*), and cryptochrome (*Cry1* and *Cry2*) \[[@r13]\]. Additional regulatory loops involving nuclear hormone receptors such as *Ror* and *Rev*-erbα are also implicated in the control of circadian clock function \[[@r13]\]. These positive and negative feedback loops drive circadian physiologic outputs by regulating the expression of downstream clock-controlled genes, such as albumin D-site-binding protein (*Dbp*) and *E~4~BP~4~* (a basic leucine zipper transcription factor). About 15--30% of the transcriptome in all tissues is under the control of clock genes depending on the tissue or the cell type \[[@r14]-[@r16]\].

Impairments in retinal function due to retinal diseases can potentially impact the central clocks and the circadian organization of the entire organism \[[@r17]\]. Diabetic retinopathy is one of the most common consequences of diabetes that affects millions of working-age adults worldwide and leads to progressive degeneration of the retina, visual loss, and blindness \[[@r18]\]. Studies in patients and animal models have shown that diabetes alters rhythmic clock gene expression in the central and peripheral clocks. In experimental or genetic models of type 1 and type 2 diabetes, pronounced phase advance or delay in the rhythms of several clock and clock-controlled genes have been reported in the heart, liver, and retina \[[@r19]-[@r22]\], whereas in the SCN and the cerebral cortex, no changes in expression were observed \[[@r22],[@r23]\]. However, we previously reported that diabetic retinopathy affects clock genes and behavioral responses of the circadian timing system to light, possibly through direct alterations of ipRGCs \[[@r24]\].

Because these changes in clock genes have been reported under diurnal conditions, it is not possible to unequivocally assess whether the effects described are due to effects on the circadian pacemaker or to complex masking processes of light. In the current study, we investigated the impact of diabetic retinopathy on the circadian expression and light response of clock and clock-controlled genes in the retina and in the SCN using a streptozotocin (STZ) mouse model of diabetes. In several models of diabetes, a dysfunction of the retinal dopaminergic system has been observed \[[@r25]-[@r27]\]. Since dopamine (DA) is involved in many physiologic aspects of retinal neuromodulation, mediation of light responsiveness, and clock gene regulation \[[@r28]-[@r30]\], we thus evaluated light-driven retinal DA as a major output marker of the retinal clock.

Methods
=======

Animals
-------

Wild-type male C57BL/6J mice (Janvier, Le-Gesest-St-Isle, France) were maintained in a temperature-controlled room (23±1 °C) under a 12 h: 12 h light-dark cycle with broadband white light at 300 lux, with food and water ad libitum. All treatments of animals were in strict accordance with current national and international regulations on animal care, housing, breeding and experimentation and are in agreement with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. The specific protocols used in this study were approved the CELYNE Committee n° C2EA42-13-02-0402-005.

Induction of experimental diabetes in mice
------------------------------------------

Diabetes was chemically induced in 3-week-old fasted male mice as previously described \[[@r24],[@r31]\]. Animals received an intraperitoneal injection of STZ (85 mg/kg, Calbiochem, San Diego, CA) dissolved in 0.01 M sodium citrate buffer (pH 4.5) during 3 successive days. The diabetic state was confirmed by measuring blood glucose levels. Mice with glucose levels higher than 2 g/l were considered to be diabetic. Age-matched non-diabetic control animals were injected with 0.01 M sodium citrate buffer. Animals were maintained until 12 weeks after the onset of diabetes. At this stage, the control group exhibited mean blood glucose of 1.66±0.17 g/l (p≤0.001), whereas the mean level in the diabetic mice was 4.99±0.3 g/l. This increase in the blood glucose level was correlated with a weight loss in the STZ group (21±1.05 g) compared to the control group (28.50±0.57 g; p≤0.001).

Circadian expression of clock and clock-controlled genes in the retina and the SCN
----------------------------------------------------------------------------------

Wild-type (n = 16) and diabetic (n = 16) mice were initially maintained under a 12 h: 12 h light-dark cycle, and subsequently, at 10 weeks post-injection, the mice were kept in constant darkness (DD) for 15 days. To quantify the circadian expression of clock and clock-controlled genes (*Clock*, *Bmal1*, *Per1--2-3*, *Cry1--2*, *Rev-erbα, Rorβ*, *Dbp*, and *E~4~BP~4~*), retinas and SCN from the same animals were collected at 12 weeks post-diabetes during the first circadian cycle every 4 h (CT0, CT4, CT8, CT12, CT16, and CT20). Pooled retinas (n = 4 for each CT and each group) from the same animal and individual SCN (n = 4 for each CT and each group) were directly collected under dim red light (below 0.1 lux), frozen on dry ice, and stored at −80 °C.

Light induction of *Per1*, *Per2*, and *c-fos* in the retina
------------------------------------------------------------

Mice were maintained under a 12 h: 12 h light-dark cycle (n = 11--12 for both groups) until 12 weeks after the onset of diabetes and subsequently maintained for one cycle under DD conditions. To analyze photic induction of *Per1*, *Per2*, and *c-fos* mRNAs, a pulse of monochromatic light (480 nm, 1.17×10^14^ photons/cm^2^/s, 15 min) was administered at circadian time 16 (CT16), the first day in DD. After the light pulse, the animals (n = 7 for each group) were returned to DD and were euthanized with cervical dislocation 30 min after the beginning of the light pulse. The dark control (n = 4--5 for each group) animals were handled identically but were not exposed to light. Two retinas from the same animal were pooled and stored at −80 °C until RNA was extracted and quantified. Handling and transfer of the animals and dissections were performed under dim red light.

Real-time RT--PCR
-----------------

Total RNA was extracted using TRIzol reagent (Invitrogen, Villebon sur Yvette, France). Total RNAs was reverse transcribed using random primers and MMLV Reverse Transcriptase (Invitrogen). Real time RT-PCR was then performed on a LightCycler™ system (Roche Diagnostics, Meylan, France). PCR reaction was performed with 1 µl of cDNA supplemented with 0.75 µl of LightCycler® FastStart Enzyme and LightCycler® FastStart Reaction Mix SYBR Green (Roche Diagnostic), 0.8 µl of forward and reverse primers (10 µM; Eurofins, Ebersberg, Germany), 1.2 µl of MgCl~2~ (4 mM; Roche Diagnostic) in a total volume of 10 µl. The thermal cycler conditions were as follows: 8 min at 95 °C, and then 45 cycles of denaturation at 95 °C for 15 s, annealing at 68 °C for 15 s and the temperature was reduced by 0.5 °C each cycle until 60 °C. Hypoxanthine ribosyl-transferase (*Hprt*) was used for normalization. Initially, two housekeeping genes were tested for RT--PCR, the *Hprt* and *36b4* genes. The *Hprt* gene was finally used for internal standardization of target gene expression as this gene exhibits only constitutively non-regulated expression in both groups and independently of the physiologic state or the experimental conditions. The efficiency and the specificity of the amplification were controlled by generating standard curves and carrying out melting curves. Relative transcript levels of each gene were calculated using the second derivative maximum values from the linear regression of cycle number versus log concentration of the amplified gene. Primer sequences are shown in [Table 1](#t1){ref-type="table"}.

###### Primers.

  **Primer**        **Sens**                **Reverse**
  ----------------- ----------------------- -----------------------
  ***Hprt***        ATCAGTCAACGGGGGACATA    AGAGGTCCTTTTCACCAGCA
  ***Clock***       GTTTGATCACAGCCCAACTC    CTCCGCTGTGTCATCTTTTC
  ***Bmal1***       CTCAGCTGCCTCGTTGCAAT    GCTGTCGCCCTCTGATCTAC
  ***Per1***        GCGTTGCAAACGGGATGTGT    GAACCTGCAGAGGTGCCAG
  ***Per2***        CCACACTTGCCTCCGAAATA    ACTGCCTCTGGACTGGAAGA
  ***Per3***        CAGTGGCAGAGACGTGCGT     GACACTGTCGATACAGTTCAT
  ***Cry1***        GCCAGCTGATGTATTTCCCAG   CGCCAGCCTCAGTAGCCAG
  ***Cry2***        GAGAGACCTCGGATGAATGC    CTCGCCACAGGAGTTGTCCA
  ***Rev-erbα***    GCTCCATCGTTCGCATCAAT    CTAGAGGGCACAGGCTGCT
  ***Rorβ***        GCGAGCACAAATTGAAGTGA    AACGGTTCCTGTTGGTTCTG
  ***E~4~BP~4~***   CGGAAGTTGCATCTCAGTCA    GCAAAGCTCTCCAACTCCAC
  ***Dbp***         CGTGGAGGTGCTAATGACCT    CGGCTCCAGTACTTCTCATC
  ***c-fos***       AGCGCCCCATCCTTACGGAC    TCAGCAGATTGGCAATCTCA

Immunohistochemistry
--------------------

Twelve weeks post-injection, at Zeitgeber time 4 (ZT4), the male mice were deeply anesthetized with ketamine (100 mg/kg) and perfused intracardially with saline followed by 4% paraformaldehyde in phosphate buffer (PB, pH 7.4). Flatmounted retinas (n = 6 for the control and n = 5 for the diabetic groups) were rinsed three times (10 min each) in 0.01 M saline PBS (0.01 M phosphate buffer, 0.09% NaCl, pH 7.4), and endogenous peroxidase activity was suppressed using a solution of 50% ethanol with 0.03% H~2~O~2~ for 1 h. Retinas were preincubated in 0.01 M PBS containing 0.3% triton and 0.1% sodium azide (PBSTA) and blocked with 1% bovine serum albumin for 2 h, and then in antityrosine hydroxylase (TH) primary antibody (1:1,000; Millipore, Fontenay ss Bois, France) for 2 days, at 4 °C. Retinas were then washed twice in PBST and reacted with the secondary goat anti-rabbit biotinylated immunoglobulin (IgG ; 1 :200 ; Vector Laboratories, Burlingame, CA) for 2 h. Immunoreactivity was visualized using a Vectastain ABC Elite kit (1:200; PK-6100, Vector Laboratories) for 90 min at room temperature, followed by incubation in 0.2% 3,3′-diaminobenzidine, 0.5% ammonium nickel sulfate, and 0.003% H~2~O~2~ in 0.05 M Tris buffer (pH 7.6). The flatmounted retinas were mounted on slides, dehydrated in graded ethanol, cleared in xylene, and coverslipped. The number of TH-positive cells was determined using the software package Mercator running on ExploraNova technology.

Biochemistry
------------

Control and diabetic mice were maintained under a 12 h: 12 h light-dark cycle. Twelve weeks after the onset of diabetes, pooled retinas from the same animal were directly collected at ZT2 and ZT14 (n = 7 for control and n = 8 for diabetic mice for each ZT time), frozen on dry ice, and stored at −80 °C until analysis. Frozen retinas were homogenized by sonication in 60 µl buffered perchloric acid 0.1 M and centrifuged at 5,000 ×g for 15 min at 4 °C. The supernatants were injected into the high-performance liquid chromatography (HPLC) separation system (column SpheriSorb RP18--5UM, mobile phase 50 mM KH~2~PO~4~, 15 mg/ml EDTA-Na, 0.26 mM sodium octyle sulfate, methanol 8%, adjusted to pH 4.5, flow rate 0.3 ml/min). DA and 3,4-dihydroxyphenylacetic acid (DOPAC) peaks were identified based on retention time, and concentrations were estimated by rationing the peak areas of each substance and their respective external standard (analytical software AZUR, Datalys, St Martin d'Heres, France). The DA and DOPAC concentrations are expressed as pg/mg tissue.

Statistical analysis
--------------------

To evaluate circadian rhythmicity in gene expression, data were analyzed with the cosinor method (Sigmaplot Systat software). Rhythmicity in gene expression was assessed by fitting the 24 h data to a cosine curve using the following equation:

f(x) = M+A x cos x (2π

x

(T- φ)/24)

T represents the time (h), M represents the mean value of the cosine curve (mesor), A represents the amplitude of the curve (half of the sinusoid), and φ the acrophase (h). Two-way ANOVA followed by the post-hoc Newman-Keuls test were used to compare the *Per1, Per2*, and *c-fos* mRNAs, DA and DOPAC concentrations, and the DOPAC/DA ratio between the control and diabetic groups. One-way ANOVA followed by the post-hoc Newman-Keuls test was used to compare the number of TH-positive cells between the control and diabetic animals.

Results
=======

Circadian expression of clock genes and clock-controlled genes in the retina and the SCN of control and diabetic animals
------------------------------------------------------------------------------------------------------------------------

The circadian expression of clock genes (*Clock*, *Bmal1*, *Per1--3*, *Cry1--2*, *Rev-erbα*, and *Rorβ*) was analyzed in the retina and the SCN and compared in diabetic mice to the age-matched control animals 12 weeks post-onset of diabetes ([Figure 1](#f1){ref-type="fig"}). In the DD conditions, cosinor analysis showed that in the whole retina, a significant rhythmicity was found in a few clock genes in the control and diabetic mice. In the control mice, only *Bmal1* (p = 0.00016) and *Per3* (p = 0.006) were rhythmic, while *Clock*, *Per1--2*, *Cry1--2*, *Rev-erbα*, and *Rorβ* did not show a significant 24 h rhythmic component (p≥0.05). In diabetic mice, *Bmal1* remained rhythmic (p≤0.05) with a significantly reduced amplitude (0.16±0.07) compared to the control mice (0.27±0.06; p≤0.05) but with a similar acrophase between the control (1.4±1.04 h) and diabetic mice (0.68±2.3 h). *Per1* (p = 0.30) and *Cry1* (p = 0.11) that were non-rhythmic in the control mice exhibited circadian expression in the diabetic mice with an acrophase of 11.79±1.5 h for *Per1* and 22.8±1.1 h for *Cry1* ([Figure 1](#f1){ref-type="fig"}, [Table 2](#t2){ref-type="table"}).

![Circadian expression of clock genes (*Per1--3, Bmal1, Clock, Cry1--2, Rev-erbα*, and *Rorβ*) and clock-controlled genes (*Dbp* and *E~4~BP~4~*) in the retina and the SCN of the wild-type and STZ-diabetic mice at 12 weeks post-diabetes. Animals were euthanized in constant darkness (DD). Pooled retinas (n = 4 for each circadian time (CT) and each group) and individual suprachiasmatic nucleus (SCN; n = 4 for each CT and each group) from the same animals were isolated every 4 h (CT0, CT4, CT8, CT12, CT16, and CT20), and mRNA levels were measured using real-time reverse transcription PCR (RT--PCR). Results are expressed as mean ± standard error of the mean (SEM). Data from CT0 are double plotted at CT24. Continuous (wild-type) and dashed (diabetic) lines represent the periodic sinusoidal function determined by Cosinor analysis. Only periodic sinusoidal functions with amplitude significantly different from zero are represented (p≤0.05, zero amplitude test).](mv-v22-959-f1){#f1}

###### Acrophase (± SD) of mRNA levels of clock and clock-controlled genes in the retina and the SCN of control and diabetic animals at 12 weeks post-diabetes.

  Gene          Acrophase (h)                             
  ------------- --------------- ------------- ----------- ---------------
  *Per1*        \-              11.79±1.5     12.7±1.14   12.32±1.02 NS
  *Per2*        \-              \-            12.07±1.2   15.02±1.05 NS
  *Per3*        14.7±1.3        \-            11.8±1.22   13.43±1.17 NS
  *Bmal1*       1.4±1.04        0.68±2.3 NS   \-          21.6±1.16
  *Clock*       \-              \-            13,7±2.09   18.53±1.42 NS
  *Cry1*        \-              22.8±1.1      10.04±0.8   15.10±1.32 \*
  *Rev-erb α*   \-              \-            8.3±0.9     11.6±2.09 NS
  *Ror β*       \-              \-            9.48±1.13   \-
  *Dbp*         7.7±1.4         7.01±0.9 NS   \-          \-
  *E~4~Bp~4~*   \-              18.02±1.52    \-          \-

Acrophase values are determined using Cosinor analysis and test of amplitude to assess goodness of fit. Only rhythms with a significant value are shown. \* p≤0.05.

In the SCN, all the genes studied (*Per1--3*, Clock, *Cry1*, *Rev-erbα*, and *Rorβ)* showed circadian expression, except *Cry2* in the control and diabetic mice, *Bmal1* in the control mice, and *Rorβ* in the diabetic mice. The expression of *Per2* showed greater amplitude in diabetic animals (0.33±0.007) compared to the control animals (0.26±0.007, p≤0.05). However, no significant difference in acrophases was observed between the diabetic and age-matched control mice except *Cry1* ([Figure 1](#f1){ref-type="fig"}, [Table 2](#t2){ref-type="table"}) that exhibited around a 5 h phase delay in the diabetic group (15.10±1.32 h) compared to 10.04±0.8 h in the control group (p≤0.05).

Cosinor analysis of the clock-controlled genes showed that in the retina and the SCN, *Dbp* exhibited a circadian rhythm with a similar acrophase in the control and diabetic groups ([Figure 1](#f1){ref-type="fig"}, [Table 2](#t2){ref-type="table"}). The acrophase was 7.7±1.4 h for the control mice and 7.07±0.9 h for the diabetic mice (p≥0.05) in the retina and 9.43±0.64 h for the control mice and 9.23±0.67 h for the diabetic mice in the SCN (p≥0.05). In the retina, *E~4~BP~4~* showed a circadian variation with an acrophase of 18.02±1.5 h only in the diabetic mice (p = 0.0002), whereas in the SCN no significant circadian rhythm was found for either group (p≥0.05).

Altered light induction of *c-fos*, *Per1* and *Per2* in the retina of diabetic mice
------------------------------------------------------------------------------------

Our previous work has shown that diabetes induces morphological changes in ipRGCs, including soma swelling and dendritic varicosities, associated with decreased *c-fos* and clock genes induction by light in the SCN at 12 weeks post-onset of diabetes \[[@r24]\]. Here, we analyzed the effect of light stimulation on the induction of *c-fos* and *Period* genes in the retina to assess the role of ipRGCs in the light response of the retinal clock. Mice were exposed to a 480 nm monochromatic light pulse of constant irradiance and duration (1.17×10^14^ photons/cm^2^/s; 15 min) at CT16, known to induce significant *Per1* and *Per2* expression \[[@r32]\]. *c-fos* and *Per1* were significantly induced by light in the control animals compared to the respective dark-exposed mice (F~(1--10)~ = 7.9; p≤0.001 for *c-fos* and F~(1--10)~ = 8.36; p≤0.001 for *Per1*), whereas no significant induction by light was observed in the diabetic mice for both genes ([Figure 2](#f2){ref-type="fig"}). A reduction in *c-fos* induction by light was observed between the control and diabetic mice (p≤0.05). ANOVA analysis showed that the expression of the *Per2* gene was not induced by light in either the control (F~(1--10)~ = 3.58; p≥0.05) or diabetic (F~(1--10)~ = 2.04; p≥0.05) mice in comparison to the respective dark control animals.

![Relative light-induced *c-fos, Per1* and *Per2* mRNA levels in the retinas of the control and diabetic mice at 12 weeks post-diabetes. The light stimulus is a 480 nm monochromatic light pulse (1.17× 10^14^ photons/cm^2^/s, 15 min duration) delivered at circadian time 16 (CT16). White bars represent animals that received the light pulse (L, n = 7 for each group). The dark control mice (D, black bars) were handled in the same way but did not received a light stimulus (n = 4--5 for each group). Data are represented as mean ± standard error of the mean (SEM). Asterisk indicates a statistically significant difference (\* p≤0.05; \*\* p≤0.01; \*\*\* p≤0.001).](mv-v22-959-f2){#f2}

Diabetes induced a significant reduction in the total number of TH-positive neurons and the retinal dopamine content
--------------------------------------------------------------------------------------------------------------------

DA is a crucial neurotransmitter involved in many physiological aspects of retinal neuromodulation, mediation of light responsiveness, and clock gene regulation \[[@r29]\]. We first evaluated the impact of diabetes on the total number of TH-positive cells in whole-mounted retinas at 12 weeks post-onset of diabetes ([Figure 3A](#f3){ref-type="fig"}). A reduction of 56% in the total number of TH-positive cells was found in the STZ-diabetic mice compared to the control animals (controls: 719.5±67.11 cells/retina and STZ-diabetic: 404.2±66.48 cells/retina with F~(1--10)~ = 15.69; p≤0.001). In the diabetic mice, the DA level was decreased at ZT2 (p = 0.04) but not at ZT14 (p≥0.05). Diabetes did not alter the DOPAC levels (F~(1--27)~ = 0.0016; p≥0.05) or the ratio of DOPAC to DA at the two zeitgeber times ((F~(1--27)~ = 0.036; p≥0.05; [Figure 3](#f3){ref-type="fig"}).

![Alteration of the dopaminergic system in diabetic mice at 12 weeks post-diabetes. **A**: Right panel: representative flatmounted retinas from a control and a streptozotocin (STZ)-diabetic animal, immunostained with tyrosine hydroxylase (TH) antibody. Scale bar = 40 µm. Left panel: total number of TH-positive cells in the control and diabetic mice at 12 weeks post-diabetes. A significant reduction in the total number of TH-positive cells was observed in the diabetic group in comparison to the age-matched control animals. Data are represented as mean ± standard error of the mean (SEM; n = 6 for the control group and n = 5 for the diabetic mice group). **B**: Dopamine (DA) and 3,4-dihydroxyphenylacetic acid (DOPAC) levels, and the DOPAC/DA ratio in wild-type and diabetic mice at 12 weeks post-diabetes and at two different Zeitgeber time (ZT) points (ZT2 and ZT14; n = 7 for control and n = 8 for diabetic mice for each ZT point). The post-hoc Newman-Keuls test shows a significant difference in the DA level at ZT2 between the control and diabetic groups, whereas no significant difference was observed at ZT14. The DOPAC content and the DOPAC/DA ratio are similar between the two groups at the two ZTs. Data are represented as mean ± SEM, \* p≤0.05.](mv-v22-959-f3){#f3}

Discussion
==========

Diabetes alters the molecular machinery of the retinal clock
------------------------------------------------------------

Dysregulation of clock gene expression has been identified as a key factor in several disease pathogenesis, including diabetes. Diabetes is associated with circadian disruption of the central and peripheral circadian clocks, such as in the heart and the liver \[[@r20],[@r33],[@r34]\]. *Db/db* mice, a model of type 2 diabetes, show the hallmark features of diabetic retinopathy associated with dampened oscillations of clock genes in the vasculature \[[@r21]\]. Inversely, *Clock* and *Bmal1* conditional mice develop type 1 diabetes \[[@r35]-[@r37]\], and *Per2* mutant mice present retinal vascular damage and neuronal loss in the bone marrow similar to that found in type 2 diabetes \[[@r38]\]. In rat models of type 1 and type 2 diabetes, the expression of several clock genes, including *Clock*, *Bmal1*, *Per1*, *Per2*, *Cry1*, and *Cry2,* are altered in the retina, whereas few effects are observed in the SCN \[[@r22],[@r23],[@r34]\]. In agreement with these studies, we found variable effects of diabetes on the expression of clock genes in the retina and only slight differences in phase and/or amplitude in the SCN. The main differences observed in the SCN include an increase in the amplitude of *Bmal1* expression and a phase delay in *Cry1* in STZ-diabetic animals compared to the control animals. In the retina of the STZ-diabetic animals, the amplitude of *Per1* and *Cry1* gene expression increased leading to a significant circadian rhythm of their expression, whereas *Per3* lost rhythmicity. However, our results disagree with the study by Wang et al.; they found a decrease in *Per1* expression and an increase in *Bmal1* expression in the retina of STZ-diabetic rats \[[@r34]\]. The discrepancy could be related to species or to experimental design. We euthanized the mice at an advanced stage of diabetes (12 weeks post-injection of STZ) in circadian conditions, whereas Wang et al. \[[@r34]\] analyzed the diurnal rhythm of clock genes at an early stage of the pathology (6 weeks post-injection).

In general, a circadian rhythm of only a few clock genes is observed in the wild-type retina in comparison to the SCN \[[@r39]\]. This has been related to the existence of several clocks in the retina that oscillate with different periods and phases, resulting in low amplitude rhythmicity or masking of coherent clock gene expression \[[@r32],[@r40]\] and cellular coupling among clock cells/layers is not uniform throughout the retina \[[@r40]\]. In the SCN, in contrast, the oscillators are strongly coupled \[[@r41]\]. Intercellular coupling confers robustness against mutations in the SCN circadian clock network, and this may confer robustness of the SCN clock versus the retinal clock against clock gene mutations \[[@r42]\] or pathological conditions.

Clock gene response to light is altered in the retina during diabetes
---------------------------------------------------------------------

Light entrains the circadian clock in the retina and the SCN and induces *c-fos*, *Per1*, and *Per2* expression \[[@r32],[@r43]-[@r45]\]. Photic entrainment of the mammalian SCN requires cones, rods, and ipRGCs \[[@r2]-[@r6]\], but their role in entrainment of the retinal clock is under debate. Two recent studies by the same group suggested that none of these photoreceptors are necessary for light entrainment of the retinal clock \[[@r46]\]. However, melanopsin has previously been shown to be involved \[[@r47]-[@r51]\]. In particular, ipRGCs provide excitatory sustained light responses to dopaminergic neurons with peak sensitivity near 480 nm, the maximum sensitivity of melanopsin \[[@r50]\]. In the absence of melanopsin, this sustained melanopsin-driven response is eliminated \[[@r51]\], and 480 nm light fails to induce *Per1* and *Per2* mRNA expression in the retinal photoreceptor layer \[[@r32]\].

We found that *c-fos* and *Per1* were induced with a 480 nm light pulse only in the control group at 12 weeks post-induction of diabetes, whereas this photic induction was abolished in the STZ-diabetic animals. The *Per2* gene was not induced by light in either group. This suggests a deficit in light-induced neuronal activation in the retina. Several studies have shown that ipRGCs are altered in diabetes \[[@r52]-[@r54]\]. Diabetes induced with STZ treatment gives rise to late neural cell death in the retina \[[@r55],[@r56]\]. We also found in the STZ-diabetic mice an atrophy of ipRGCs associated with decreased photic signaling to the SCN at 12 weeks post-onset of diabetes \[[@r24]\]. Because the diminished light input in the retina of the STZ-diabetic mice was not likely due to the development of cataract or changes in opsin levels \[[@r24]\], our results suggest that the altered photic response of the retinal clock may result from impaired ipRGCs during diabetes.

Diabetes induced a reduction in TH-positive cells and retinal dopamine level
----------------------------------------------------------------------------

DA, synthesized and released by a sparse population of amacrine cells \[[@r57],[@r58]\], is implicated in many aspects of retinal neuromodulation and plays a central role in the adaptation to light and clock gene regulation \[[@r28]-[@r30],[@r43]\]. In the present study, we demonstrated a reduction in the DA content at ZT2 in mice at 12 weeks post-diabetes compared to controls, whereas no significant difference was observed at ZT14. The DOPAC/DA ratio, which is an indicator of the DA metabolism, was similar between the control and diabetic animals at both ZT times. This result is in accordance with previous studies that show a dysfunction of the dopaminergic system in the early or late stages of development of diabetes in mouse and rat models \[[@r25],[@r27],[@r52],[@r59],[@r60]\]. However, the underlying mechanisms are unclear. The decline in DA content may be related to a reduced number of retinal dopaminergic neurons, low levels of DA synthesis, or an impairment of DA release from the cells. In the present study, we reported a 56% reduction in the total number of TH-positive cells in STZ-diabetic mice compared to age-matched controls with no difference in DA metabolism that may account for the reduced DA level.

In addition, the retinal DA content and metabolism are not circadian in C57BL/6 mice, and DA release is strictly light-driven \[[@r61],[@r62]\]. The reduction of the DA content only at ZT2 may also be induced by the decrease in light induction of the *c-fos* and *Per1* genes in the STZ-diabetic retina. According to the anatomic and functional relations between ipRGCs and DAergic amacrine cells \[[@r50],[@r51],[@r63]\], ipRGCs may be involved as we have shown that light induction of TH mRNA, DA, and clock genes requires melanopsin \[[@r32]\]. In addition, in dystrophic retinas with degenerated rod and cone photoreceptors, light is still capable of increasing retinal DA release \[[@r64],[@r65]\].

In conclusion, the effect of STZ-induced diabetes differs between the SCN and the retina and leads to a dysregulation of the retinal clock organization and, in particular, the response to light. In addition, disturbances in the dopaminergic system, the main output of the retinal clock, have been observed expressed as a decrease in the number of TH-positive amacrine cells and DA content.
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